Literature DB >> 22075380

Synergistic antitumor effect of adenovirus-mediated hING4 gene therapy and (125)I radiation therapy on pancreatic cancer.

Yaodong Zhao1, Chenghai Su, Hongyan Zhai, Yue Tian, Weihua Sheng, Jingcheng Miao, Jicheng Yang.   

Abstract

Pancreatic cancer has a poor prognosis, even with surgery. ING4 is a member of the inhibitor of growth (ING) tumor suppressor family that has potent inhibitory effects on a variety of tumors; meanwhile, radiotherapy is a common adjunctive therapy for pancreatic cancer. Prior to this study, the effectiveness of a combination of ING4 gene-therapy and radiotherapy against pancreatic cancer had been unknown. In this study, we demonstrated that either ING4 or (125)I radiotherapy treatment could induce Panc-1 pancreatic cancer cell growth suppression and apoptosis in vitro. Furthermore, both treatments inhibited tumor growth and angiogenesis of Panc-1 pancreatic cancer subcutaneously xenografted in vivo. Moreover, the combination therapy had a synergistic effect.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075380     DOI: 10.1016/j.canlet.2011.11.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.

Authors:  Liyu Cao; Shunhua Chen; Cong Zhang; Cong Chen; Nana Lu; Yan Jiang; Yongping Cai; Yu Yin; Jianming Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.

Authors:  Shanshan Wang; Sören Reinhard; Chengyi Li; Min Qian; Huiling Jiang; Yilin Du; Ulrich Lächelt; Weiyue Lu; Ernst Wagner; Rongqin Huang
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

3.  Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.

Authors:  Shijie Li; Tianli Fan; Hongtao Liu; Jiangtao Chen; Changjiang Qin; Xuequn Ren
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

4.  Epirubicin Enhances the Anti-Cancer Effects of Radioactive 125I Seeds in Hepatocellular Carcinoma via Downregulation of the JAK/STAT1 Pathway.

Authors:  Lei Guo; Jiali Sun; Changjun Wang; Yang Wang; Ya Wang; Dong Li; Yuliang Li
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

Review 5.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

6.  Overexpression of Inhibitor of Growth 4 Enhances Radiosensitivity in Non-Small Cell Lung Cancer Cell Line SPC-A1.

Authors:  Xuan Pan; Rui Wang; Haibo Bian; Wei De; Ping Zhang; Chenchen Wei; Zhaoxia Wang
Journal:  Technol Cancer Res Treat       Date:  2016-07-04

7.  Chromatin Memory in the Development of Human Cancers.

Authors:  Yixin Yao; Thomas L Des Marais; Max Costa
Journal:  Gene Technol       Date:  2014-08-11

8.  ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.

Authors:  Fuliang Qian; Qingqing Hu; Yali Tian; Jie Wu; Dapeng Li; Min Tao; Lei Qin; Bairong Shen; Yufeng Xie
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

9.  ING1 and 5-azacytidine act synergistically to block breast cancer cell growth.

Authors:  Satbir Thakur; Xiaolan Feng; Zhong Qiao Shi; Amudha Ganapathy; Manoj Kumar Mishra; Peter Atadja; Don Morris; Karl Riabowol
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

Review 10.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.